| Application no. and date | 17817175.7 (espacenet) (Federated) (European Patent Register), 20171201 | | Patent/reg. no. and date | DK/EP 3548026, 20210120 | | Publication date | 20191009 | | Priority no. and date | EP 16382584, 20161201 | | EP pub. no. and date |
EP 3548026 20191009 | | Effective date | | | Applicant/owner | Minoryx Therapeutics S.L., Av. Ernest Lluch 32
08302 Mataró, Barcelona, ES | | Applicant ref. no. | V52773DK00 | | Inventor | PIZCUETA LALANZA, Maria Pilar, c/o Minoryx Therapeutics S.L.
Av. Ernest Lluch 32
08302 Mataró, Barcelona, ES,
MARTINELL PEDEMONTE, Marc, c/o Minoryx Therapeutics S.L.
Av. Ernest Lluch 32
08302 Mataró, Barcelona, ES | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4439 (2006.01) , A61K 45/06 (2006.01) , A61P 1/16 (2006.01) | | Title | 5-[[4-[2-[5-(1-Hydroxyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolinidin-2,4-dion til behandling af ikke-alkoholisk fedtleversygdom | | Int. application no. | IB2017057587 | | Int. publication no. | WO2018100557 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
